Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 11/20 | 0.77 |
| ▸ | HTR2C | P28335 | 2/20 | 0.77 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.77 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.77 |
| ▸ | HTR1A | P08908 | 1/20 | 0.77 |
| ▸ | DRD2 | P14416 | 1/20 | 0.77 |
| ▸ | DRD4 | P21917 | 1/20 | 0.77 |
| ▸ | DRD5 | P21918 | 1/20 | 0.77 |
| ▸ | HTR1D | P28221 | 1/20 | 0.77 |
| ▸ | HTR1E | P28566 | 1/20 | 0.77 |
| ▸ | HTR7 | P34969 | 1/20 | 0.77 |
| ▸ | HRH1 | P35367 | 1/20 | 0.77 |
| ▸ | DRD3 | P35462 | 1/20 | 0.77 |
| ▸ | HTR2B | P41595 | 1/20 | 0.77 |
| ▸ | HTR5A | P47898 | 1/20 | 0.77 |
| ▸ | HTR6 | P50406 | 1/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1889935 | 0.99 | HTR2A (0.76) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| SCHEMBL30886892 | 0.93 | HTR2A (0.80) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| SCHEMBL20970933 | 0.93 | HTR2A (0.80) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| SCHEMBL30886886 | 0.93 | HTR2A (0.80) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| Lysergide SCHEMBL28318015 | 0.88 | HTR2A (0.94) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| Lysergide SCHEMBL28097238 | 0.88 | HTR2A (0.94) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| Lysergide SCHEMBL23741954 | 0.87 | HTR2A (1.00) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| Lysergide SCHEMBL113755 | 0.87 | HTR2A (1.00) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| Lysergide SCHEMBL12401704 | 0.87 | HTR2A (1.00) | HTR2AHTR2CADRB2ADRB1HTR1A | |
| Lysergide SCHEMBL467940 | 0.87 | HTR2A (1.00) | HTR2AHTR2CADRB2ADRB1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129064-A1 | PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) | TERRAN BIOSCIENCES INC. | 2025-04-24 | — | — | US | disclosed |
| WO-2025080689-A1 | LIPID PRODRUGS OF BROMOLYSERGIDE AND USES THEREOF | SEAPORT THERAPEUTICS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025080689-A1 | LIPID PRODRUGS OF BROMOLYSERGIDE AND USES THEREOF | SEAPORT THERAPEUTICS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2023141636-A1 | PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) | TERRAN BIOSCIENCES INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| WO-2023107966-A1 | SALT AND SOLID FORMS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND ANALOGS | TERRAN BIOSCIENCES, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| CN-102164603-B | Be used for the treatment of method and the test kit of cluster headache disease | THE MCLEAN HOSPITAL CORP. (US) | 2015-11-25 | — | — | CN | disclosed |
| CN-102164603-B | Be used for the treatment of method and the test kit of cluster headache disease | THE MCLEAN HOSPITAL CORP. (US) | 2015-11-25 | — | — | CN | disclosed |
| US-20130252996-A1 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | MEDIZINISCHE HOCHSCHULE HANNOVER (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20130252996-A1 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | MEDIZINISCHE HOCHSCHULE HANNOVER (DE) | 2013-09-26 | — | — | US | disclosed |
| US-8415371-B2 | Methods and kits for treating cluster headache disorders | THE MCLEAN HOSPITAL CORPORATION (US) | 2013-04-09 | — | — | US | disclosed |
| CN-102657868-A | 5-hydroxy tryptamine 2 receptor antagonist or transporter inhibitor for treating fatty liver or hyperlipemia | UNIV CHINA PHARMA | 2012-09-12 | — | — | CN | disclosed |
| CN-102164603-A | Methods and kits for treating cluster headache disorders | MCLEAN HOSPITAL CORP | 2011-08-24 | — | — | CN | disclosed |
| CN-102164603-A | Methods and kits for treating cluster headache disorders | MCLEAN HOSPITAL CORP | 2011-08-24 | — | — | CN | disclosed |
| EP-2331100-A2 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | The McLean Hospital Corporation (US) | 2011-06-15 | — | — | EP | disclosed |
| EP-2331100-A2 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | The McLean Hospital Corporation (US) | 2011-06-15 | — | — | EP | disclosed |
| US-20110104275-A1 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
| US-20110104275-A1 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
| WO-2010033392-A3 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2010-06-17 | — | — | WO | disclosed |
| WO-2010033392-A2 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2010-03-25 | — | — | WO | disclosed |
| WO-2010033392-A2 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2010-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104275-A1 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | KIT, CCKBR, HCRTR2 | HTR2A 46/4885HTR2C 73/4885ADRB2 482/4885 |
| US-20130252996-A1 | METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS | KIT, CCKBR, HCRTR2 | HTR2A 46/4885HTR2C 73/4885ADRB2 482/4885 |
| US-20250129064-A1 | PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) | GBA2, GBA1, SLC18A2 | HTR2A 9/4885HTR2C 16/4885ADRB2 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.